Paper Titles in Periodical
International Letters of Chemistry, Physics and Astronomy
ILCPA Volume 50

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

ILCPA > ILCPA Volume 50 > Synthesis, in Silico Molecular Docking Studies and...
< Back to Volume

Synthesis, in Silico Molecular Docking Studies and Antibacterial Activity of 4-(4-Hydrazinylbenzyl)-1,3-Oxazolidin-2-One against DNA Gyrase Enzyme

Full Text PDF


The molecular docking and antimicrobial activity studies of synthesized 4-(4-hydrazinylbenzyl)-1,3-oxazolidin-2-one were performed, in order to provide insights into the mechanism of action of potential antimicrobial drugs for resistant microorganisms. antimicrobial activity of compounds was investigated in vitro under aseptic conditions, using the disk diffusion method, against various gram positive and gram negative pathogenic microorganisms such as Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Bacillus substilis and Staphylococcus aureus. Molecular docking was performed to study the binding activity of synthesized hydrazide onto the active site of DNA Gyrase Protein in an effort to increase the understanding of the action and resistance of synthesized hydrazide in this bacterium.


International Letters of Chemistry, Physics and Astronomy (Volume 50)
P. J. Rosy et al., "Synthesis, in Silico Molecular Docking Studies and Antibacterial Activity of 4-(4-Hydrazinylbenzyl)-1,3-Oxazolidin-2-One against DNA Gyrase Enzyme", International Letters of Chemistry, Physics and Astronomy, Vol. 50, pp. 43-49, 2015
Online since:
May 2015

[1] Rallas, S.; Gulerman, N.; Erdeniz, H. Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2, 5- disubstituted-1, 3, 4-oxadiazolines. Farmaco 2002, 57, 171-174.


[2] Fang, G. -M.; Li, Y. -M.; Shen, F.; Huang, Y. -C.; Li, J. -B.; Lin, Y.; Cui, H. -K.; Liu, L. Protein chemical synthesis by ligation of peptide hydrazides. Angew. Chem. Int. Ed. 2011, 50, 7645–7649.


[3] R. Bonicke and J.Z. Kracht, Infektionskranch, 139, 140 (1954).

[4] S.K. Agarwal, R. Chandra, R. Gupta and D.R. Tutlani, J. Inst. Chem., 59(5), 225 (1987).

[5] C.N. Haksar, R.C. Malhotra, G. Pandya, and R.K. Sethi, Lab. J. Sc. Technol., 9B, 34 (1971).

[6] F. Binon and R. Royer, J. Chem. Soc., 1358 (1953).

[7] M. Sechi, U. Azzena, M.P. Delussu, R. Dallocchio, A. Dessi, A. Cosseddu, N. Pala and N. Neamati, Molecules, 13, 2442 (2008).


[8] L.U. Kraatz, B.K. Wolfgang, B.G.A. Wolfram, E.T. Andreas and C.M. Norbert, US Patent No. 5929118 (1999).

[9] A. Maiti, S. Ghosh, (1989) ; Indian Journal of Chemistry, vol . 29, pp- 980–983.

[10] N. Dharmaraj, P. Viswanalhamurthi, K. Natarajan, (2001) ; Trans. Met. Chem. 26, 105.

[11] C.H. Colins, P.M. Lyne, (1970) ; Microhiul Methods, University Park Press, Baltimore.

[12] R.M. Silverstein, G.C. Bassler, T.C. Morrill, Spectrometric Identification of Organic Compounds, fourth ed., Wiley, New York, (1981).

[13] Haack,T.; Fattori,R.; Napoletano,M.; Pellacini,F.; Fronza,G.; Raffaini,G.; Ganazzoli,F. ( 2005) ; Bioorg. Med. Chem . vol . 13, pp-4425-4433.


[14] Strappaghetti,G.; Brodi,C.; Giannaccini, G; Betti,L., (2006) ; Bioorg. Med. Chem. Lett. vol . 16, pp- 2575-2579.

[15] Al-Assar,F.; Zelenin K.N.; Lesiovskaya E.E.; Bezant, I.P.; Chakchir , B.A. (2002) ; Pharm. Chem. vol . 36, pp- 598-603.


[16] H.L. Singh, A.K. Vershney, (2006) ; Bioinorganic chemistry and application . pp.1-7.

[17] Jain ,R.P.; Vederas J.C. (2004) ; Bioorg. Med. Chem. Lett. vol . 14, pp- 3655-3658.

[18] A. Scozzafava, L. Menabuoni , F. Mincione, G. Mincione , and C. T. Supuran , (2001) Bioorganic and medicinal chemistry Letters vol. 11, no. 4, pp -575-582.


[19] M. A. Elsome , J .M. T. Hamilton-Miller, W. Brmfitt and W. C. Noble., (1996) ; Journal of Antimicrobial Chemotherapy, vol. 37, no5, pp.911-918.

[20] Amit Poshiya et al, Synthesis studies of bacterial dna-gyrase inhibitors, IJPT, 2011 3(3)| 3048-3059.

[21] Smita pawar et al., Synthesis of novel antimicrobial derivatives of 3-substituted pyrrolidine2, 5-diones using pharmacophore hybrid approach: part-I, Int J Pharm Pharm Sci, 2014, 6(2), 486-490.

[22] Aviraboina Siva Prasad et al Der Pharma Chemica, 2012, 4 (1): 347-351.

[23] E.W. Koneman, S.D. Allen, W.M. Janda, P.C. Schreckenberger, Colour Atlas and Text Book of Diagnostic Microbiology, 5th ed., Jt. Editor W.C. Winn, Lippincott, Philadelphia, P.A., 1997, 185.

[24] V. Cleidson, M. Simone, F.A.S. Elza Artur S. Jr., Braz. J. microbiol., 2007, 38(2), 369-380. ( Received 19 April 2015; accepted 30 April 2015 ).

Show More Hide
Cited By:
This article has no citations.